You are here

Jesduvroq

Docs likely to be 'cautious' when prescribing GSK's first-in-class anemia drug Jesduvroq, survey finds

Fierce Pharma

Thu, 02/9/23 - 06:05 pm

This Week at FDA: Restructuring at inspections office, new guidances and staff, and more

RAPS.org

Mon, 02/6/23 - 10:34 am

regulatory inspections

GSK's oral anemia drug Jesduvroq scores partial FDA nod after 2 rivals suffered rejections

Fierce Pharma

Thu, 02/2/23 - 10:28 am

chronic kidney disease